ADP Diagnostics is an innovative diagnostics company based in Carrickfergus, Northern Ireland, supplying products to the Clinical, Veterinary and Food science sectors.
As a science graduate of Ulster University and now with 25 years experience in clinical diagnostics, my goal for ADP Diagnostics is to make it a world leader in speciality quality controls. We work with carefully chosen manufacturers and strive to provide bespoke solutions for our customers. Research & Development, validations and trials are carried out in our own laboratory. The excellent laboratories in our local Belfast hospitals also provide invaluable validation data for our clinical products.
ADP Diagnostics is an ISO 9001:2015 registered company, recognising the quality of our administrative and management systems.
Greg Simpson Bsc.
Managing Director
| COVID-19 RAPID TEST FROM NASOPHARYNGEAL SWAB | ||
| FAST |
FROM ADP DIAGNOSTICS, SUPPLIER OF RAPID TESTS TO THE NHS FOR 15 YEARS |
15 MINUTE TEST |
| 98.7 % ACCURACY |
A rapid in vitro Lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen protein. |
96.7 % SENSITIVITY |
| UK SUPPLIED | OVER 25 YEARS EXPERIENCE IN CLINICAL DIAGNOSTICS | MHRA CERTIFIED |
| ECONOMICAL | 20 TEST KIT | LESS THAN £20 PER TEST |
12 February 2021
PSA Ultra Low Quality Control is a product that we developed in response to numerous requests for a low level control to keep pace with the ever-increasing sensitivity of PSA assays. The control is widely used in Ireland by cancer testing centres as it is ideal for monitoring PSA levels post-prostatectomy.
The control is validated against the Roche immunoassay on the Roche Cobas® analyser.
The ‘PSA: Low level’ control is manufactured as stabilised serum from human origin. The concentrations of the QC have been chosen to ensure optimal assay performance at a critical sensitivity level.
A low level or undetectable PSA level is defined as ≤0.06 ng/mL or 0.02ng/mL by the ‘American Society for therapeutic radiology and oncology consensus panel’. As defined by the intuition it is agreed that a 6-12 month ‘undetectable PSA’ level is a prediction of disease-free survival ‘DFS’. Therefore an ultra-sensitive assay is beneficial.
Reference: Int. J. Radiation Oncology Biol. Phys Vol.37 No.5 pp 1035-1041, 1997
The control is stable up to the expiry date when stored at 2-8°c. When opened the control is stable for a period of 14 days when stored at 2-8°c. The kit size is 10 x 1ml.
Contact us for instrument specific values or further information.
03 February 2021
After months of investment, research, development and trials, ADP Diagnostics in has successfully launched its new whole blood glucose quality control, a world first. The impact of this new product is significant, in that for the first time it enables clinicians and point of care specialists to use a quality control material for POC glucose testing, that is as close as possible to a patient sample.
The whole blood glucose quality control is supplied as a 2-level control x 3 vials of each level, vials are 2ml. The control is compatible with all major manufacturers’ Glucometers and instrument specific values are available. Once opened, the vials are stable for 4 months. Vials should be stored at 2-8C.
The new whole blood glucose control is of interest to any laboratory that implements a policy of continuous improvement in clinical excellence. Using this control also enables the laboratory to comply with ISO15189 guidelines which stipulate:
“The laboratory shall use quality control materials that react to the examining system in a manner as close as possible to patient samples. Quality control materials shall be periodically examined with a frequency that is based on the stability of the procedure and the risk of harm to the patient from an erroneous result.”
(Reference: ISO 15189:2012(E): 5.6.2.2 Quality control materials)
ADP Diagnostics has built a strong reputation for innovation and clinical excellence, having already launched a number of world first quality control products including a single vial Serum Indices Quality Control, and a Xanthochromia Quality Control. The company’s products are being used throughout Ireland, UK, and several other international markets. ADP Diagnostics has become a key supplier of niche quality control sera to a number of National Quality Assessment Schemes worldwide. The control is currently being used by Labquality Finland, one of Europe’s major EQA scheme organisers.
Contact us for instrument specific values or for further information.
*The whole blood glucose quality control has been developed in association with Dr L. McGrath of Torax Biosciences.
